SNDL — SNDL Inc
NASDAQ · Pharmaceuticals · Pharmaceuticals
- Latest Close
- $1.51
- 30-Day Move
- -11.2%
- Market Cap
- $353M
- Shares Outstanding
- 257,400,000
- P/B Ratio
- 0.54
- ROE
- -1.4%
Analyst consensus: Buy · 8 analysts
SNDL Inc
A read-only Alphactor snapshot forSNDL Inc. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-21
Topline snapshot
Latest Close
$1.51
30-Day Move
-11.2%
Market Cap
$353M
Shares Outstanding
257,400,000
P/B Ratio
0.54
ROE
-1.4%
$1.51
-11.2%last 90 delayed daily bars
90D High
$2.34
90D Low
$1.28
Avg Volume
2,258,701
Gross margin is running at 27.3%, which gives a quick read on operating quality before you open the full model.
Net margin is -1.7%, useful for comparing SNDL against peers in Pharmaceuticals.
SNDL is down 11.2% over the last 30 trading days shown on this page.
Latest operating income is $10M, which helps anchor the headline ratios with an actual earnings figure.
Composite Fair Value
$11.38
Rule of 40
9.0%
Dark Pool Short %
23.4%
Latest Close
$1.51
30-Day Move
-11.2%
Market Cap
$353M
Shares Outstanding
257,400,000
P/B Ratio
0.54
ROE
-1.4%
ROA
-1.2%
Gross Margin
27.3%
Operating Margin
-85.0%
Net Margin
-1.7%
Debt / Equity
0.15
Current Ratio
4.88
Latest Revenue
$252M
Revenue
$252M
Gross Profit
$70M
Operating Income
$10M
Net Income
$9M
Gross Margin
2733.0%
Net Margin
-167.0%
Current Ratio
4.88
Debt / Equity
0.15
Fair Value
$11.38
Upside / Downside
+653.9%
Signal
Undervalued
Implied Growth
-12.3%
DCF
$4.07
EV/Rev
$18.70
Growth Assumption
9.9%
Discount Rate
10.5%
Terminal Growth
2.0%
Base FCF
$58M
Valuation spread
After signup
The full valuation workspace goes deeper
Adjust DCF growth, discount, and terminal assumptions instead of relying on one static snapshot.
Open the deeper balance-sheet and cash-flow views to inspect debt, liquidity, and cash generation line by line.
Compare multiple valuation models against peers and save your own thesis instead of re-reading a fixed public state.
Negative growth / decline priced in
Altman Z
0.55
Distress
Piotroski
6
Moderate (4-6)
Cash Conversion
-4.50x
Rule of 40
9.0%
Concerning
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2022-12-31 | $712M | $-61M | $-335M | $-18M |
| 2023-12-31 | $909M | $-100M | $-173M | $-25M |
| 2024-12-31 | $920M | $-34M | $-95M | $44M |
| 2025-12-31 | $946M | $-4M | $-16M | $58M |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
After signup
The full sentiment workspace adds context
Go past the public headlines into fuller article history, source cross-checks, and deeper narrative tracking.
Tie news into alerts, watchlists, and conviction changes instead of browsing one static batch of stories.
| ETF | Shares | Weight | As Of |
|---|---|---|---|
| Amplify ETF Trust-Amplify Alternative Harvest ETF | 4,970,342 | 0.02% | 2025-12-31 |
| AdvisorShares Trust-AdvisorShares Pure US Cannabis ETF | 2,580,976 | 0.01% | 2026-02-28 |
| AdvisorShares Trust-AdvisorShares Pure Cannabis ETF | 1,012,645 | 0.00% | 2026-02-28 |
| Cambria ETF Trust-Cambria Cannabis ETF | 352,842 | 0.00% | 2026-03-31 |
| SPDR INDEX SHARES Fd.S-State Street SPDR PORT. Developed World ex-US E | 290,423 | 0.00% | 2026-02-28 |
| Amplify ETF Trust-Amplify Seymour Cannabis ETF | 203,556 | 0.00% | 2025-12-31 |
| DFA INVESTMENT DIMENSIONS GROUP INC-DFA Intl Small Cap Value PORT. | 172,438 | 0.00% | 2026-01-31 |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 164,900 | 0.00% | 2026-02-28 |
After signup
The deeper ownership view shows who is leaning in
Open richer institutional and holder diffs to see position changes across filings instead of one static snapshot.
Use those ownership shifts alongside conviction and alerts in the full app workflow.
Invesco
Filed 2026-02-19
--
--
Citadel Advisors
Filed 2025-11-14
$6M
--
Goldman Sachs
Filed 2026-02-10
$2M
+40.8%
Man Group
Filed 2025-11-14
$1M
--
Qube Research & Technologies
Filed 2026-02-17
$1M
+103.1%
4.13
Consensus
Buy—
—
—
8
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.
Balance Sheet Deep Dive
Balance sheet changes lead income statements by 2-6 quarters. Net debt, receivables days, and goodwill are the lines that move stocks first.